Introducing the Neurology Milestones 2.0
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 28, 2021
- Accepted in final form December 27, 2021
- First Published January 11, 2022.
Article Versions
- Previous version (January 11, 2022 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Jeffrey J. Dewey, MD, MHS*,
- Nicole Chiota-McCollum, MD, MEd*,
- Diana Barratt, MD, MPH,
- Laura Edgar, EdD, CAE,
- Laurie Gutmann, MD,
- Anita V. Shelgikar, MD, MHPE,
- Jayne Ward, DO,
- Shannon M. Kilgore, MD;
- on behalf of the Neurology Milestones 2.0 Work Group
- Jeffrey J. Dewey, MD, MHS*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nicole Chiota-McCollum, MD, MEd*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH/NCATS, 1KL2 TR003016-01, Curriculum consultant, 2019
Johns Hopkins University School of Education; Senior Educational Advisor for students enrolled in the JHU Masters of Education in Health Professions Program.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Diana Barratt, MD, MPH,
NONE
NONE
NONE
NONE
NONE
NONE
In 2020, I was employed as a clinical trials investigator. Evolution Research Group. However, not related to this publication.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) American Board of Psychiatry and Neurology Faculty Innovation in Education Award, 2019-2020 (2) American Academy of Neurology Education Research Grant, 2018-2019
NONE
NONE
NONE
NONE
NONE
NONE
- Laura Edgar, EdD, CAE,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I am a full-time employee of ACGME.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Laurie Gutmann, MD,
(1) Commercial: Expansion therapeutics - scientific advisory board
NONE
NONE
NONE
NONE
Up-to-Date Online 2007 - present, Hypokalemic and Hyperkalemic Periodic Paralysis and Neuromuscular Junction Toxins
NONE
(1) Biogen/Ionis- consultant (2) Dyne therapeutics - consultant for protocol development
NONE
NONE
NONE
(1) Expansion Therapeutics (2) Harmony Biosciences
(1) NIH 1 U01 NS069498-01 A1, (2) 3P50NS044283-07S1, (3) 1 U01 NS026835-01A1, (4) 1 U01 NS058728-01, (5) 1 U01 NS077179-01.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Anita V. Shelgikar, MD, MHPE,
NONE
NONE
NONE
Journal of Clinical Sleep Medicine, Editorial Board member
NONE
NONE
NONE
NONE
NONE
(1) American Academy of Sleep Medicine, Board of Directors (2) American Academy of Sleep Medicine Foundation, Board of Directors (3) American Board of Sleep Medicine, Board of Directors
Sleep Medicine, 65% of effort, 11 years at current institution
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jayne Ward, DO,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1)Sanofi Genzyme, (2) BMS Celgene
NONE
NONE
(1) Biogen
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Shannon M. Kilgore, MD;
NONE
NONE
NONE
Continuum Lifelong Learning in Neurology, Editorial Board member, 2013-
NONE
NONE
Spouse is employed by Apple, Inc, but not in the health technology division.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Spouse has received stock from Apple, Inc as part of employee compensation.
NONE
NONE
NONE
NONE
NONE
- on behalf of the Neurology Milestones 2.0 Work Group
- From the Yale School of Medicine (J.J.D.), New Haven, CT; University of Virginia School of Medicine (N.C.-M.), Charlottesville; Lee Memorial Health Systems (D.B.), Fort Myers, FL; Accreditation Council for Graduate Medical Education (L.E.), Chicago, IL; Indiana University School of Medicine (L.G.), Indianapolis; University of Michigan (A.V.S.), Ann Arbor; Michigan State University (J.W.), East Lansing; United States Department of Veterans Affairs (S.M.K.), Palo Alto Health Care System, CA; and Stanford University (S.M.K.), CA.
- Correspondence
Dr. Dewey jeffrey.dewey{at}yale.edu
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
- Reader Response: Introducing the Neurology Milestones 2.0
- Arielle M Kurzweil, Neurologist, NYU Grossman School of Medicine
Submitted March 16, 2022
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Glossary
- The First Neurology Milestones: Development & Reactions
- Neurology Milestones 2.0: The Next Iteration
- Recommended Use of Neurology Milestones 2.0
- Introducing the Supplemental Guide
- The Future of the Milestones
- Discussion
- Study Funding
- Disclosure
- Acknowledgment
- Appendix 1 Authors
- Appendix 2 Coinvestigators
- Footnotes
- References
- Figures & Data
- Info & Disclosures